Ipsen Ltd: UK Public Sector Contracts Won & Awards

Large organisationCompanies House: Private Limited CompanyLondonNationwide (UK)Main market: Pharmaceutical products

Companies House06751069 ↗ · Active

Where they win
i

34 awards (33 for a named lot, 97%, 1 for a whole procedure with no lot named) · top CPV classes, shares of all 34 awards. An award may cover more than one class.

3360 Pharmaceutical products34 awards · 100% · 33 awards naming a lot + 1 whole-procedure awards
Attributable award value
i
£7.5mOn 2 of 34 award records; the five largest make 100%. Largest rows below.
Largest published awards
i
AuthorityAwardedTermPublished value
Proprietary DrugsNHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)——£5,496,771 †
Proprietary DrugseTenderwales——£1,969,400 †

Where their buyers are
i

ITL1 region of the buyer office · known for 25 of 25 awarded procedures · each procedure counts once

Greater London12 procedures · 48%
Scotland6 procedures · 24%
North West England4 procedures · 16%
Wales (Cymru)2 procedures · 8%
Northern Ireland1 procedure · 4%

Who they sell to
i

Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier

Authority type · official UK type when published, else name/id class, else not classified · by award records (a single panel can dominate)
i
  • NHS & health91%(31 awards)
    31 of 34 awards are NHS & health (91%).
  • Type not classified9%(3 awards)
    3 of 34 awards are Type not classified (9%).

Share = of the 25 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.

Contracts ending
i

26 of 36 awards carry an end date, 7 estimated from the duration · not a retender forecast

ContractEndsPublished value
Lanreotide Injection Prefilled Syringes (unbundled - without homecare)3 Jan 2027 estimated£1,324,548 ceiling
Lanreotide Injection Prefilled Syringes (bundled - with homecare)3 Jan 2027 estimated£681,188 ceiling
Medicinal Products - Direct to Trust2 Jun 2027 estimated£210,000,000 ceiling
Medicinal Products - with Pharma Funded Homecare Services2 Jun 2027 estimated£174,000,000 ceiling

Recent awards

Latest 30 of 34 award records naming this supplier

Contracts Finder adds 2 more procedures won by this supplier, mostly below the Find a Tender threshold or from before 2025. Each is counted once beside any Find a Tender copy; they are in the totals, not in this list.

Award / procedureAuthorityAwardedPublished value
Triptorelin (Decapeptyl®)The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£1,553,548 †
framework ceiling · not attributable revenue
Triptorelin (Decapeptyl®)The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£1,553,548 †
framework ceiling · not attributable revenue
Proprietary DrugseTenderwalesNot published£1,969,400 †
from the contract notice
Medicinal Products - Direct to TrustBusiness Services Organisation Procurement and Logistics ServiceNot published£210,000,000 †
framework ceiling · 1 of 31 appointed suppliers
Medicinal Products - with Pharma Funded Homecare ServicesBusiness Services Organisation Procurement and Logistics ServiceNot published£174,000,000 †
framework ceiling · 1 of 21 appointed suppliers
NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
Lanreotide Injection Prefilled Syringes (unbundled - without homecare)The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£1,324,548 †
framework ceiling · 1 of 2 appointed suppliers
Lanreotide Injection Prefilled Syringes (bundled - with homecare)The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£681,188 †
framework ceiling · 1 of 2 appointed suppliers
Gonadorelin AnaloguesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£2,028,890 †
framework ceiling · not attributable revenue
NP90219c Triptorelin (Decapeptyl®)The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£375,130 †
framework ceiling · not attributable revenue
About this data
  • One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
  • Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
  • Regions in the buyer chart describe the buyer office, not where the work is delivered or the supplier’s registered address.
  • Contract end dates. Published on 19 of 36 awards, estimated from the published duration on 7 more (marked “estimated”); those feed “Contracts ending”. Published values in that list come from either source; Contracts Finder figures are shown as published and stay out of this profile’s money totals.
  • Source. Official UK public procurement notices (Find a Tender, Contracts Finder and Public Contracts Scotland), reused under the Open Government Licence v3.0, updated through the day and rebuilt nightly. Not every figure uses every feed, and each one shows how many records it rests on: see the methodology. Spotted something wrong? Tell us.